-
-
-
-
-
-
-
Immuneering reports Q1 2026 financial results and clinical updates
-
-
-
-
-
-
-
Teva Pharma (TEVA) PT Raised to $42 at BofA Securities
-
-
-
-
-
-
-
Teva Pharma (TEVA) PT Raised to $41 at Piper Sandler; 'Much To Be Bullish About'
-
-
-
-
-
-
-
Increasing unusual put option volume: GGAL FSLY FROG CENX XPO BK PINS AEVA WEN OKE TEVA
-
-
-
-
-
-
-
Teva Pharma (TEVA) call put ratio 1 call to 1 put into updated guidance
-
-
-
-
-
-
-
Teva Pharma (TEVA) PT Raised at Piper Sandler on Multiple Expansion Potential
-
-
-
-
-
-
-
Piper Sandler: 'Biotech Has a Heartbeat: 17 Stocks to Own Through YE25'
-
427,822 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

